ArticleBreast cancer research : BCR2005

Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.

Hiroko Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.